CVA Family Office, LLC

Family Office

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 1802084 DENVER, CO

Position in ALNY

as of Mar 31, 2026 · filed Apr 29, 2026 Compact

Position Value

$30,440

+$6,979 QoQ

Shares Held

+55.9% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2022

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Mar 31, 2026

CVA Family Office, LLC holds $673,464 across 40 Biotechnology names. ALNY ranks #5 (4.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	472	$210,766
2	REGN	Regeneron Pharmaceuticals, Inc.	194	$149,892
3	MRNA	Moderna, Inc.	1,701	$86,410
4	INCY	Incyte Corp	904	$85,084
5	ALNY	Alnylam Pharmaceuticals, Inc. This page	92	$30,440
6	JAZZ	Jazz Pharmaceuticals plc	84	$15,880
7	EXEL	Exelixis, Inc.	270	$11,580
8	BBIO	BridgeBio Pharma, Inc.	146	$10,841

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$30,440	92	+55.9%	Shares	Sole	2026-04-29
2025-12-31	$23,461	59	-4.8%	Shares	Sole	2026-01-12
2025-09-30	$28,272	62	+1.6%	Shares	Sole	2025-10-30
2025-06-30	$19,891	61	+64.9%	Shares	Sole	2025-07-31
2025-03-31	$9,990	37	+48.0%	Shares	Sole	2025-04-16
2024-12-31	$5,882	25	+316.7%	Shares	Sole	2025-01-07
2024-09-30	$1,650	6	+100.0%	Shares	Sole	2024-10-10
2024-03-31	$448	3	-80.0%	Shares	Sole	2024-04-10
2023-06-30	$2,849	15	0.0%	Shares	Sole	2023-07-10
2023-03-31	$3,004	15	+50.0%	Shares	Sole	2023-04-27
2022-12-31	$2,376	10	+100.0%	Shares	Sole	2023-02-22
2022-09-30	$1,000	5	-50.0%	Shares	Sole	2022-11-22
2022-06-30	$1,458	10	0.0%	Shares	Sole	2022-07-11
2022-03-31	$1,632	10	—	Shares	Sole	2022-04-22
No filing history on record for this holder in this stock.